![Hank Safferstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hank Safferstein
Directeur Général chez
Generian Pharmaceuticals, Inc.
Profil
Hank Safferstein, PhD, JD, MBA, currently serves as a Senior Advisor, UPMC Enterprises and CEO, Generian, a UPMC portfolio company.
He is Board Director of Ariel Precision Medicine.
Previously, he was Senior Vice President of Cognition Therapeutics, a clinical stage, small molecule, Alzheimer’s disease company and Adjunct Professor at Carnegie Mellon University.
He was Founder and CEO of Cognition Therapeutics and Complexa, Inc., a clinical stage biotechnology company focused on fibrosis and inflammation for orphan disease indications.
Dr. Safferstein served as Vice President, Business Development, for Omrix Biopharmaceuticals, a commercial-stage company that develops and markets biosurgical and passive immunotherapy products (acquired by J&J) and was Vice President, Business Development for Acorda Therapeutics, a central nervous system drug development and marketing company.
Prior to joining Acorda Therapeutics, Dr. Safferstein served in various business development and marketing positions with Bristol-Myers Squibb.
From 1991-1997, he was Director, Technology Transfer at the National Heart, Lung and Blood Institute and Cooperative Venture Manager for the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
Dr. Safferstein was an NIH Post-Doctoral Fellow and Fellow of the Multiple Sclerosis Society.
Dr. Safferstein received a BA in Biochemistry from Rutgers University, a PhD in Human Anatomy and Neurobiology from the University of Louisville, a JD from the American University, Washington College of Law and an MBA from Columbia University.
He is an active member of the Maryland Bar.
Postes actifs de Hank Safferstein
| Sociétés | Poste | Début |
|---|---|---|
PLSG Capital Investment Programs
 PLSG Capital Investment Programs Investment ManagersFinance Alternative investment manager | Corporate Officer/Principal | - |
Generian Pharmaceuticals, Inc.
 Generian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops gain-of-function drugs that activate key cellular networks | Directeur Général | 01/09/2019 |
UPMC Enterprises
 UPMC Enterprises Investment ManagersFinance UPMC Enterprises invests in companies located across the globe. The firm targets companies operating in the fields of health care and technology sectors. It provides financing for early and later-stage transactions. | Consultant / Advisor | 01/01/2018 |
Ariel Precision Medicine, Inc.
 Ariel Precision Medicine, Inc. Medical/Nursing ServicesHealth Services Operates as a digital health platform and provides precision medicine solutions for diagnosis, monitoring and treatment of complex chronic diseases and disorders | Directeur/Membre du Conseil | 01/03/2017 |
Anciens postes connus de Hank Safferstein
| Sociétés | Poste | Fin |
|---|---|---|
| COGNITION THERAPEUTICS, INC. | Directeur Général | 28/10/2016 |
Omrix Biopharmaceuticals, Inc.
 Omrix Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops biosurgical and immunotherapy solutions | Corporate Officer/Principal | 31/05/2007 |
| ACORDA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2005 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 31/12/1999 |
National Heart, Lung & Blood Institute
 National Heart, Lung & Blood Institute General GovernmentGovernment Promotes the prevention and treatment of heart, lung and blood diseases | Corporate Officer/Principal | 01/01/1997 |
Formation de Hank Safferstein
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Acorda Therapeutics, Inc.
 Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
Omrix Biopharmaceuticals, Inc.
Omrix Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops biosurgical and immunotherapy solutions | Health Technology |
Brainstage, Inc.
 Brainstage, Inc. Miscellaneous Commercial ServicesCommercial Services Provides technologies for healthcare and drug development | Commercial Services |
Multiple Sclerosis Society
 Multiple Sclerosis Society Miscellaneous Commercial ServicesCommercial Services Engages in supporting, researching and raising funds for sclerosis | Commercial Services |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Louisville
 University of Louisville Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransPharma Medical Ltd.
 TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Provides development and commercialization of drugs | Health Technology |
Pittsburgh Life Sciences Green House
 Pittsburgh Life Sciences Green House Investment ManagersFinance PLSG invests in companies located in the United States, primarily in Western Pennsylvania. The firm focuses on the life sciences sector. It provides financing for seed, early and growth stage capital requirements. | Finance |
PLSG Capital Investment Programs
PLSG Capital Investment Programs Investment ManagersFinance Alternative investment manager | Finance |
Cognition Therapeutics, Inc.
 Cognition Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage neuroscience company that develops drugs to help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders | Health Technology |
National Institute of Allergy & Infectious Diseases
 National Institute of Allergy & Infectious Diseases General GovernmentGovernment Operates as an agency of the United States department of health and human services | Government |
National Heart, Lung & Blood Institute
National Heart, Lung & Blood Institute General GovernmentGovernment Promotes the prevention and treatment of heart, lung and blood diseases | Government |
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on discovering and developing therapies for the treatment inflammatory and metabolic diseases | Health Technology |
American University Washington College of Law
 American University Washington College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ariel Precision Medicine, Inc.
Ariel Precision Medicine, Inc. Medical/Nursing ServicesHealth Services Operates as a digital health platform and provides precision medicine solutions for diagnosis, monitoring and treatment of complex chronic diseases and disorders | Health Services |
UPMC Enterprises
UPMC Enterprises Investment ManagersFinance UPMC Enterprises invests in companies located across the globe. The firm targets companies operating in the fields of health care and technology sectors. It provides financing for early and later-stage transactions. | Finance |
Generian Pharmaceuticals, Inc.
Generian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops gain-of-function drugs that activate key cellular networks | Health Technology |
